Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19
Taylor Morganstein, Ziyad S. Haidar, Joshua Trivlidis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12955-12955
Open Access | Times Cited: 20

Showing 20 citing articles:

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 151
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
Sally Singh, Molly M Baldwin, Enya Daynes, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 709-725
Open Access | Times Cited: 80
Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease
Matthew Preteroti, Emily T. Wilson, David H. Eidelman, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease
Tingting Liu, Haojie Wu, Lin Sun, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3259-3282
Open Access | Times Cited: 4
ACE2 PET to reveal the dynamic patterns of ACE2 recovery in an infection model with pseudocorona virus
Xiao Li, Wei Yin, Ao Li, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 10
Targeting mevalonate pathway by zoledronate ameliorated pulmonary fibrosis in a rat model: Promising therapy against post‐COVID‐19 pulmonary fibrosis
Reham Hussein Mohamed, Nesma Hussein Abdel hay, Nesma Mohamed Fawzy, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 4, pp. 703-717
Closed Access | Times Cited: 2
Pharmacological inhibition of the ACE/Ang-2/AT1 axis alleviates mechanical ventilation-induced pulmonary fibrosis
Jinhua Feng, Xi Huang, Qiaoyi Xu, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111855-111855
Closed Access | Times Cited: 2
Advances in Biomarkers for Diagnosis and Treatment of ARDS
Ruiqi Ge, Shou Zhen Wang, Zhiyong Peng
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3296-3296
Open Access | Times Cited: 7
Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy
Xiaoyan Zuo, Sixin Ren, He Zhang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients
Adrian Krygier, Dagmara Szmajda‐Krygier, Rafał Świechowski, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1845-1845
Open Access | Times Cited: 9
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19
Elisabeth Gómez Moyano, Francisco Javier Pavón, Jorge Rodríguez‐Capitán, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2405-2405
Open Access | Times Cited: 1
The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19
Reyhaneh Niayesh‐Mehr, Mojtaba Kalantar, Giulio Bontempi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Integrin β1 is a key determinant of the expression of angiotensin-converting enzyme 2 (ACE2) in the kidney epithelial cells.
Md Saimon Mia, Md. Delowar Hossain, Emerson Woodbury, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151316-151316
Open Access | Times Cited: 4
Interstitial lung disease—From pulmonary perspective to pathogenesis, multidisciplinary approach and treatment
Ching‐Yi Lee
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 5, pp. 823-824
Open Access | Times Cited: 4
Potential hypothesis for the increased risk of Parkinson´s disease following COVID-19
Raffaella Mormile, Cristina Mormile, Carmine Picone
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Equivocating and Deliberating on the Probability of COVID-19 Infection Serving as a Risk Factor for Lung Cancer and Common Molecular Pathways Serving as a Link
Abdelbasset Amara, Saoussen Trabelsi, Abdul Hai, et al.
Pathogens (2024) Vol. 13, Iss. 12, pp. 1070-1070
Open Access
ACE2 in pulmonary diseases
Qing Lin, Hongpeng Jia
Elsevier eBooks (2023), pp. 285-316
Closed Access
Changes in the expression of genes encoding ACE2 and innate immunity molecules (TLR7, IFN-α, IL-1β, TNF) in elderly patients with COVID-19
V. V. Grechenko, O. S. Uvarova, T.V. Gromova, et al.
Immunologiya (2023) Vol. 44, Iss. 1, pp. 72-82
Open Access
Renin and angiotensin-converting enzyme 2 expression in the uterus and placenta in immune-dependent and preeclampsia-associated spontaneous abortions in mice
К. А. Artemyeva, И.И. Степанова, N. V. Nizyaeva, et al.
CLINICAL AND EXPERIMENTAL MORPHOLOGY (2023) Vol. 12, Iss. 4, pp. 53-61
Open Access

Vak Komissiya, Ḿanaging Editor, Kulikova Science, et al.
CLINICAL AND EXPERIMENTAL MORPHOLOGY (2023) Vol. 12, Iss. 4
Open Access
Page 1

Scroll to top